Literature DB >> 28786561

Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.

Juline Poirson1, Elise Biquand2, Marie-Laure Straub1, Patricia Cassonnet2, Yves Nominé3, Louis Jones4, Sylvie van der Werf2, Gilles Travé3, Katia Zanier1, Yves Jacob2, Caroline Demeret2, Murielle Masson1.   

Abstract

Protein ubiquitination and its reverse reaction, deubiquitination, regulate protein stability, protein binding activity, and their subcellular localization. These reactions are catalyzed by the enzymes E1, E2, and E3 ubiquitin (Ub) ligases and deubiquitinases (DUBs). The Ub-proteasome system (UPS) is targeted by viruses for the sake of their replication and to escape host immune response. To identify novel partners of human papillomavirus 16 (HPV16) E6 and E7 proteins, we assembled and screened a library of 590 cDNAs related to the UPS by using the Gaussia princeps luciferase protein complementation assay. HPV16 E6 was found to bind to the homology to E6AP C terminus-type Ub ligase (E6AP), three really interesting new gene (RING)-type Ub ligases (MGRN1, LNX3, LNX4), and the DUB Ub-specific protease 15 (USP15). Except for E6AP, the binding of UPS factors did not require the LxxLL-binding pocket of HPV16 E6. LNX3 bound preferentially to all high-risk mucosal HPV E6 tested, whereas LNX4 bound specifically to HPV16 E6. HPV16 E7 was found to bind to several broad-complex tramtrack and bric-a-brac domain-containing proteins (such as TNFAIP1/KCTD13) that are potential substrate adaptors of Cullin 3-RING Ub ligases, to RING-type Ub ligases implicated in innate immunity (RNF135, TRIM32, TRAF2, TRAF5), to the substrate adaptor DCAF15 of Cullin 4-RING Ub ligase and to some DUBs (USP29, USP33). The binding to UPS factors did not require the LxCxE motif but rather the C-terminal region of HPV16 E7 protein. The identified UPS factors interacted with most of E7 proteins across different HPV types. This study establishes a strategy for the rapid identification of interactions between host or pathogen proteins and the human ubiquitination system.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990HPVzzm321990; interactomic; protein complementation assay; ubiquitination

Mesh:

Substances:

Year:  2017        PMID: 28786561     DOI: 10.1111/febs.14193

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  27 in total

1.  Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.

Authors:  Marcel Chris Conrady; Irina Suarez; Gergö Gogl; Desiree Isabella Frecot; Anna Bonhoure; Camille Kostmann; Alexandra Cousido-Siah; André Mitschler; JiaWen Lim; Murielle Masson; Thomas Iftner; Frank Stubenrauch; Gilles Travé; Claudia Simon
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

2.  Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).

Authors:  Arushi Vats; Oscar Trejo-Cerro; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2022-08-02       Impact factor: 6.549

3.  High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression.

Authors:  Juline Poirson; Irina Paula Suarez; Marie-Laure Straub; Alexandra Cousido-Siah; Paul Peixoto; Eric Hervouet; Anne Foster; André Mitschler; Noella Mukobo; Yassmine Chebaro; Dominique Garcin; Sevda Recberlik; Christian Gaiddon; Danièle Altschuh; Yves Nominé; Alberto Podjarny; Gilles Trave; Murielle Masson
Journal:  J Virol       Date:  2022-04-27       Impact factor: 6.549

Review 4.  Role of Virally-Encoded Deubiquitinating Enzymes in Regulation of the Virus Life Cycle.

Authors:  Jessica Proulx; Kathleen Borgmann; In-Woo Park
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

5.  Comparative Profiling of Ubiquitin Proteasome System Interplay with Influenza A Virus PB2 Polymerase Protein Recapitulating Virus Evolution in Humans.

Authors:  Elise Biquand; Juline Poirson; Marwah Karim; Marion Declercq; Nicolas Malausse; Patricia Cassonnet; Cyril Barbezange; Marie-Laure Straub; Louis Jones; Sandie Munier; Nadia Naffakh; Sylvie van der Werf; Yves Jacob; Murielle Masson; Caroline Demeret
Journal:  mSphere       Date:  2017-11-22       Impact factor: 4.389

6.  SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.

Authors:  Lisa M Pinatti; Wenjin Gu; Yifan Wang; Ahmed Elhossiny; Apurva D Bhangale; Collin V Brummel; Thomas E Carey; Ryan E Mills; J Chad Brenner
Journal:  Cancer       Date:  2021-06-23       Impact factor: 6.860

Review 7.  PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6.

Authors:  Lennox Chitsike; Penelope J Duerksen-Hughes
Journal:  Molecules       Date:  2021-05-18       Impact factor: 4.411

Review 8.  The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis.

Authors:  Leslie Olmedo-Nieva; J Omar Muñoz-Bello; Adriana Contreras-Paredes; Marcela Lizano
Journal:  Viruses       Date:  2018-01-18       Impact factor: 5.048

Review 9.  Structural Insights in Multifunctional Papillomavirus Oncoproteins.

Authors:  Irina Suarez; Gilles Trave
Journal:  Viruses       Date:  2018-01-15       Impact factor: 5.048

Review 10.  High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis.

Authors:  Nicole S L Yeo-Teh; Yoshiaki Ito; Sudhakar Jha
Journal:  Int J Mol Sci       Date:  2018-06-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.